Kevzara
Kevzara ingredients
| Active ingredient | Strength |
|---|---|
| Sarilumab | 200 mg/1.14mL, 150 mg/1.14mL |
What Kevzara is used for
The FDA lists the approved uses on the official label (below). In the EU, sarilumab is approved as Kevzara for:
Rheumatoid arthritisKevzara in combination with methotrexate (MTX) is indicated for the treatment of moderately to severely active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (DMARDs). Kevzara can be given as monotherapy in case of intolerance to MTX or when treatment with MTX is inappropriate. Polymyalgia rheumaticaKevzara is indicated for the treatment of polymyalgia rheumatica (PMR) in adult patients who have had an inadequate response to corticosteroids or who experience a relapse during corticosteroid taper. Polyarticular juvenile idiopathic arthritis Kevzara is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA; rheumatoid factor positive or negative polyarthritis and extended oligoarthritis) in patients 2 years of age and older, who h…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Kevzara
- Generic name
- Sarilumab
- Made by
- Sanofi-Aventis U.S. LLC
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Interleukin-6 Receptor Antagonist
- FDA approval
- Biologic licence (BLA) BLA761037
- On the US market since
- 2017
Official information
- Kevzara prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Sarilumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Kevzara?
Kevzara (Sarilumab) is a specialist medicine made by Sanofi-Aventis U.S. LLC, approved by the US FDA.
What are the ingredients of Kevzara?
Kevzara contains Sarilumab (200 mg/1.14mL, 150 mg/1.14mL).
Is Kevzara approved in Europe?
The same active substance is approved in the EU as Kevzara.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA